OmniVision GmbH
Tobias Kohl currently serves as the Head of R&D at OmniVision GmbH since March 2017, overseeing research and development, project management, regulatory approval, and medical science with a team of five. Prior experience includes roles as Senior Scientist in Pharmaceutical Development at Gen Plus GmbH, Project Coordinator at A. Menarini Research and Business Service GmbH, and Project Coordinator at Berlin-Chemie AG, focusing on project planning, laboratory trials for solid and parenteral dosage forms, and regulatory support. Additionally, Tobias held the position of Deputy Head of Production at Salutas Pharma GmbH. Educational qualifications include a PhD in Molecular Biology from Ludwig-Maximilians-Universität München and a trainee program in bulk manufacturing and primary blister packaging.
This person is not in any teams
OmniVision GmbH
1 followers
High-quality ophthalmic preparations. The well-being of our patients and the joy of vision. This is just a small part of the mission we have set ourselves. We are an owner-managed, family pharmaceutical company looking ahead to the future. Our area of expertise is ophthalmology, with particular focus on the development and marketing of ophthalmic preparations for patients, ophthalmologists and pharmacists. Over the past years, we have grown steadily - not only throughout Germany, but also internationally and, as we and our experience have grown, so has our wide range of products. Today, we are proud to be ranked among the top five leading ophthalmological companies. Whether in Germany, Spain, Italy, Austria or Switzerland - OmniVision stands for a vision of a clear view and of providing high-quality and affordable preparations for the benefit of the patient.